Midpregnancy Doppler Ultrasound of the Uterine Artery in Metformin- Versus Placebo-Treated PCOS Women: A Randomized Trial
Author(s) -
Solhild Stridsklev,
Sven M. Carlsen,
Øyvind Salvesen,
Ilka Clemens,
Eszter Vanky
Publication year - 2014
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2013-3227
Subject(s) - medicine , polycystic ovary , uterine artery , metformin , gestational diabetes , pregnancy , gynecology , preeclampsia , obstetrics , placebo , gestation , insulin , insulin resistance , alternative medicine , pathology , biology , genetics
Metformin is used to reduce pregnancy complications in women with polycystic ovary syndrome (PCOS), although it is not approved for this indication and solid evidence is lacking. Midpregnancy Doppler ultrasound is one of the best methods for prediction of adverse pregnancy outcome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom